参考文献 References
[1] EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones [J]. J Hepatol, 2016. 65(1): p. 146-181.
[2] Einstein, D.M., et al., The insensitivity of sonography in the detection of choledocholithiasis [J]. AJR Am J Roentgenol, 1984. 142(4): p. 725-728.
[3] Cronan, J.J., US diagnosis of choledocholithiasis: a reappraisal [J]. Radiology, 1986. 161(1): p. 133-134.
[4] Hunt, D.R., Common bile duct stones in non-dilated bile ducts? An ultrasound study [J]. Australas Radiol, 1996. 40(3): p. 221-222.
[5] Gibson, R.N., et al., Accuracy of computed tomographic intravenous cholangiography (CT-IVC) with iotroxate in the detection of choledocholithiasis [J]. Eur Radiol, 2005. 15(8): p. 1634-1642.
[6] Cabada Giadás, T., et al., Helical CT cholangiography in the evaluation of the biliary tract: application to the diagnosis of choledocholithiasis [J]. Abdom Imaging, 2002. 27(1): p. 61-70.
[7] Mallick, R., et al., Single-session laparoscopic cholecystectomy and ERCP: a valid option for the management of choledocholithiasis [J]. Gastrointest Endosc, 2016. 84(4): p. 639-645.
[8] Ding, G., W. Cai, and M. Qin, Single-stage vs. two-stage management for concomitant gallstones and common bile duct stones: a prospective randomized trial with long-term follow-up [J]. J Gastrointest Surg, 2014. 18(5): p. 947-951.
[9] Molvar, C. and B. Glaenzer, Choledocholithiasis: Evaluation, Treatment, and Outcomes [J]. Semin Intervent Radiol, 2016. 33(4): p. 268-276.
[10] Cai, J.S., S. Qiang, and Y. Bao-Bing, Advances of recurrent risk factors and management of choledocholithiasis [J]. Scand J Gastroenterol, 2017. 52(1): p. 34-43.
[11] Mergener, K. and R. A. Kozarek, Therapeutic pancreatic endoscopy [J]. Endoscopy, 2005. 37(3): p. 201-207.
[12] Riff, B.P. and V. Chandrasekhara, The Role of Endoscopic Retrograde Cholangiopancreatography in Management of Pancreatic Diseases [J]. Gastroenterol Clin North Am, 2016. 45(1): p. 45-65.
[13] Yadav, D., N. Agarwal, and C.S. Pitchumoni, A critical evaluation of laboratory tests in acute pancreatitis [J]. Am J Gastroenterol, 2002. 97(6): p. 1309-1318.
[14] Takada, T., et al., TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis [J]. J Hepatobiliary Pancreat Sci, 2013. 20(1): p. 1-7.
[15] Itoi, T., et al., TG13 indications and techniques for biliary drainage in acute cholangitis (with videos) [J]. J Hepatobiliary Pancreat Sci, 2013. 20(1): p. 71-80.
[16] Miura, F., et al., TG13 flowchart for the management of acute cholangitis and cholecystitis [J]. J Hepatobiliary Pancreat Sci, 2013. 20(1): p. 47-54.
[17] Kiriyama, S., et al., New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines [J]. J Hepatobiliary Pancreat Sci, 2012. 19(5): p. 548-556.
[18] Khashab, M.A., et al., Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis [J]. Clin Gastroenterol Hepatol, 2012. 10(10): p. 1157-1161.
[19] Sugiyama, M. and Y. Atomi, The benefits of endoscopic nasobiliary drainage without sphincterotomy for acute cholangitis [J]. Am J Gastroenterol, 1998. 93(11): p. 2065-2068.
[20] Freeman, M.L., et al., Complications of endoscopic biliary sphincterotomy [J]. N Engl J Med, 1996. 335(13): p. 909-918.
[21] Ueki, T., et al., Comparison between emergency and elective endoscopic sphincterotomy in patients with acute cholangitis due to choledocholithiasis: is emergency endoscopic sphincterotomy safe? [J]. J Gastroenterol, 2009. 44(10): p. 1080-1088.
[22] Eto, K., et al., Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial [J]. J Hepatobiliary Pancreat Sci, 2015. 22(12): p. 825-830.
[23] Banks, P.A., et al., Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus [J]. Gut, 2013. 62(1): p. 102-111.
[24] Shen, H.N., et al., Effects of gender on severity, management and outcome in acute biliary pancreatitis [J]. PLoS One, 2013. 8(2): p. e57504.
[25] Lévy, P., et al., Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients [J]. Pancreatology, 2005. 5(4-5): p. 450-456.
[26] Forsmark, C.E. and J. Baillie, AGA Institute technical review on acute pancreatitis [J]. Gastroenterology, 2007. 132(5): p. 2022-2044.
[27] Kelly, T.R. and D.S. Wagner, Gallstone pancreatitis: a prospective randomized trial of the timing of surgery [J]. Surgery, 1988. 104(4): p. 600-605.
[28] Stone, H.H., T.C. Fabian, and W.E. Dunlop, Gallstone pancreatitis: biliary tract pathology in relation to time of operation [J]. Ann Surg, 1981. 194(3): p. 305-312.
[29] Safrany, L., et al., [Endoscopic papillotomy for acute pancreatitis caused by biliary disease (author's transl)] [J]. Dtsch Med Wochenschr, 1980. 105(4): p. 115-119.
[30] Neoptolemos, J.P., et al., Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones [J]. Lancet, 1988. 2(8618): p. 979-983.
[31] Tumi, A., et al., ERCP in a cohort of 759 cases: A 6-year experience of a single tertiary centre in Libya [J]. Arab J Gastroenterol, 2015. 16(1): p. 25-28.
[32] Siiki, A., et al., ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases [J]. Scand J Surg, 2012. 101(1): p. 45-50.
[33] Freeman, M.L. and N.M. Guda, Prevention of post-ERCP pancreatitis: a comprehensive review [J]. Gastrointest Endosc, 2004. 59(7): p. 845-864.
[34] Wu, X., G. Li, and Z. Liu, A rare case of duodenum perforation after biliary stenting under endoscopic retrograde cholangiopancreatography: a case report [J]. Ann Transl Med, 2020. 8(24): p. 1690.
[35] Jeurnink, S.M., et al., Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge [J]. Surg Endosc, 2011. 25(9): p. 2892-2900.
[36] Moffatt, D.C., et al., Risk factors for ERCP-related complications in patients with pancreas divisum: a retrospective study [J]. Gastrointest Endosc, 2011. 73(5): p. 963-970.
[37] Katsinelos, P., et al., Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist [J]. Ann Gastroenterol, 2014. 27(1): p. 65-72.
[38] Kimura, Y., et al., TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis [J]. J Hepatobiliary Pancreat Sci, 2013. 20(1): p. 8-23.
[39] Li, S., et al., Risk factors for recurrence of common bile duct stones after endoscopic biliary sphincterotomy [J]. J Int Med Res, 2018. 46(7): p. 2595-2605.
[40] Deng, F., et al., Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study [J]. World J Clin Cases, 2019. 7(9): p. 1028-1037.